Tag: David Van Duin

High neighborhood deprivation is linked to both greater antimicrobial resistance and higher short‑term mortality in Enterobacterales infections. For North Carolina, the implications are clear. Tackling AMR requires not only new drugs and diagnostics but also addressing healthcare disparities that leave vulnerable populations at greater risk. Chapel Hill, NC — A...

Carbapenem-resistant Enterobacterales (CRE) are an important threat to the health of solid organ transplant recipients (SOTr). However, data comparing outcomes of SOTr with CRE to non-SOTr with CRE is lacking. David Van Duin, MD, PhD, performed a cohort study within 2 prospective, multicenter, cohort studies. The epidemiology, desirability of outcome rankings,...

ID Week took place October 16-19 in Los Angeles, CA, the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists. UNC’s Division of Infectious Diseases was...

Antimicrobial Resistant (AMR) research at the UNC Institute for Global Health and Infectious Diseases brings together collaborators from schools and departments across UNC. Following is an interview with David van Duin, MD, PhD, Brian Conlon, PhD, Luther Bartelt, MD, Tessa Andermann, MD, MPH, and Jonathan Juliano, MD, MSPH, DTM&H. Why is...

A nationwide analysis of a large, geographically diverse cohort of adults in the U.S. suggests there is an increased risk for hospital-acquired carbapenem-resistant enterobacterales (CRE) bloodstream infections among racial and ethnic minorities. Felicia Ruffin, PhD, is a researcher at Duke University School of Medicine in the research group of Vance...

Matthew Burns, age 33, was diagnosed with cystic fibrosis as a child, and for years experienced repeated lung infections. When the need for intravenous therapy and oxygen became more frequent, he received a lung transplant, a lifesaving opportunity for hope and healing. But a transplant surgery that might typically require...

Climate change has been described as the single biggest health threat facing humanity. Physician-researchers through the Institute for Global Health and Infectious Diseases (IGHID), UNC’s engine for global health research, are actively engaged in a variety of efforts to prepare and protect the health of the most vulnerable populations. Some...

From discovery to prevention to treatment, researchers at UNC-Chapel Hill are working to understand and mitigate the global rise of untreatable infections. Nearly every one of us has had an ailment that was treated with an antibiotic. Think about what would happen if that treatment didn’t work. More than 2.8...

IGHID has a new hub of collaborative work focused on combating antimicrobial resistance (AMR).  Leveraging the Institute’s pan-university framework, the program brings together expertise in basic science, pharmacology, epidemiology, clinical research and environmental studies from schools and departments all across UNC. Led by David van Duin, MD, PhD, Gauri Rao,...

By the spring of 2020, the urgency of the COVID-19 pandemic caused many researchers affiliated with UNC’s Institute for Global Health and Infectious Diseases to pivot their studies to focus on testing, treatment and prevention of the SARS-CoV-2 virus. Here, a look at some of the projects underway in the...

    A new study by the Multi-Drug-Resistant Organism Network of the Antibacterial Resistance Leadership Group (ARLG) has found that strains of carbapenem-resistant enterobacterales (CRE), a major threat to vulnerable patient populations, are more diverse than previously thought. The MDRO Network is led by UNC Infectious Diseases investigator David van...